GNPNAT1 and osteosarcoma: Four HBP-related genes (GFPT, GNPNAT, PGM3, and UAP1) can be used to guide immunologic and targeted therapies for osteosarcoma, with significant predictive value for osteosarcoma prognosis (Su et al., 2022).